SV Health Investors

SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.

Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments.

With over $2 billion in capital under management in seven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.

SV Health Investors, established in 1993 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Health Care, Medical, Medical Device, Financial Services, Venture Capital, Finance, Banking, Biotechnology, Enterprise Software, Consumer. The organization boasts a portfolio of 309 investments, with an average round size of $34.6M and 89 successful exits. Their recent investments include LensX Lasers, Versant Ventures, InterWest Partners, Venture Investors, EBR Systems. The highest investment round they participated in was $682.8B. Among their most notable exits are LensX Lasers and Versant Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.